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Summary
Activation of extracellular-signal-regulated protein ki-
nase (Erk) is central to growth-factor-receptor-medi-
ated signaling including that originating from the T cell
antigen receptor. It integrates cytoplasmic signals to
effect changes in transcription associated with differ-
entiation, proliferation, and survival. In this report, we
present an analysis of mice with targeted deletions in
Erk1 and Erk2 to assess the relationship between Erk
activity and cell-cycle progression, thymocyte devel-
opment, and lineage commitment. These studies show
that Erk is selectively retained during  selection-
driven proliferation, and yet Erk1/2 are not required
to complete differentiation to CD4+CD8+ preselection
stage of development. Erk activity is essential for the
process of positive selection, and it differentially af-
fects CD4 and CD8 T cell maturation; yet, diminished
expression itself is not sufficient to alter lineage com-
mitment.
Introduction
T cell development proceeds in an ordered progression
that includes at least three important checkpoints. The
first major checkpoint occurs at an early DN3 (CD4−CD8−
CD44−CD25+) stage in development, a stage that de-
pends upon signals from the pre-TCR (T cell antigen
receptor). Pre-Tα associates with the product of the
TCR β chain gene to convey the presence of a prod-
uctive TCR β chain gene rearrangement. Signaling from
pre-TCR requires such molecules as Lck and Lat (Mol-
ina et al., 1992; Zhang et al., 1999), and this sets off a
number of differentiation events that include: downreg-
ulation of CD25 and RAG; six to eight rounds of cell
division; and differentiation to the CD4+CD8+ (DP) stage
of development. The second checkpoint, termed posi-
tive selection, passes DP thymocytes for promotion to
CD4 or CD8 T cells. It is based on TCR specificities for*Correspondence: shedrick@ucsd.eduself-encoded peptides associated with MHC class II or
MHC class I molecules expressed on the cortical epi-
thelium. Positive selection confers upon the T cell pop-
ulation an ability to receive persistent survival signals
through the TCR and interrogate antigen-presenting
cells throughout the body for the presence of self and
foreign peptides. Positive selection also involves many
of the same TCR-linked signaling components impor-
tant for pre-TCR signaling, although the outcome is
very different. Signals through the TCR are intimately
involved in the fate decision to differentiate into either
a CD4 helper T cell or a CD8 cytotoxic T cell, but they
do not promote cell division. A third checkpoint follows
positive selection, and it is based on the TCR recogni-
tion of self-peptide-MHC complexes present on den-
dritic cells and medullary epithelial cells (Kappler et al.,
1987; Guidos et al., 1990; Egerton et al., 1990; Ander-
son et al., 2002). At this stage, the outcome of TCR
signaling is once again quite different, and it results in
cell death. The signaling cascades of negative selec-
tion are poorly characterized but appear to culminate
in the activity of Bim (Villunger et al., 2004).
A number of studies have implicated the MAP kinase
pathway in the program of T cell development. Domi-
nant-interfering and constitutively active forms of Mek1
revealed that the MAP kinase pathway is important for
the first β selection checkpoint (Crompton et al., 1996),
and studies using Mek1 inhibitors were consistent with
this result (Sharp et al., 1997; Bommhardt et al., 1999).
The transgenic expression of dominant-interfering and
constitutively active forms of Ras, Raf, or Mek1 all im-
plicated the MAP kinase pathway in positive selection
(Swan et al., 1995; Alberola-Ila et al., 1995; O’Shea et
al., 1996), though none of these studies suggested a
role for this pathway in the CD4 versus CD8 lineage-
commitment decision. In contrast, the expression of a
gain-of-function (hypersensitive) Erk2 transgene or the
use of Mek1 inhibitors in FTOC showed that the
strength of signal through the MAP kinase pathway can
differentially promote the development of CD4 or CD8
T cells (Sharp et al., 1997; Bommhardt et al., 1999;
Sharp and Hedrick, 1999). Further work showed that
duration of the MAP-kinase-pathway signals can influ-
ence lineage commitment (Kaye, 2000; Adachi and
Iwata, 2002; Nishida et al., 2004).
Erk1/2 constitute a focal point of the MAP-kinase-
pathway signaling in mammalian cells. These two
highly homologous serine-threonine kinases are acti-
vated by tyrosine and threonine dual phosphorylation
and, in turn, broadcast this activation to both cytoplas-
mic signaling complexes and nuclear transcription fac-
tors (Chang and Karin, 2001; Pouyssegur et al., 2002;
Morrison and Davis, 2003; Alberola-Ila and Hernandez-
Hoyos, 2003). Erk is likely to be the origin of a ramifying
signal-transduction program that affects many aspects
of cell physiology. Mice deficient in signaling intermedi-
ates upstream of Erk1/2 exhibit a severe defect in posi-
tive selection (Priatel et al., 2002; Wen et al., 2004),
whereas mice deficient for transcription factors known
to be downstream of Erk1/2 exhibit somewhat less se-
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2002; Rivera et al., 2000). The implication is that there is
redundancy or that other pathways may emanate from
Erk1/2 and affect the outcome of TCR-mediated signal-
ing. The role of the MAP kinase pathway in negative
selection is less well characterized, although most
studies have not found that it makes an important con-
tribution (Swan et al., 1995; Alberola-Ila et al., 1996;
Sharp et al., 1997; Bommhardt et al., 2000; Mariathasan
et al., 2000).
In order to determine the importance of Erk1 and
Erk2, both together and individually, we have analyzed
mice selectively deficient for Erk1 (Mapk3), Erk2 (Mapk1),
or both Erk1 and Erk2. Previous results showed that
Erk1-deficient mice are viable and ostensibly normal
(Pages et al., 1999), whereas Erk2-deficient mice ex-
hibit early embryonic lethality (Hatano et al., 2003; Yao
et al., 2003; Saba-El-Leil et al., 2003) (C.D.K. and
S.M.H., unpublished results). To overcome early lethal-
ity, we generated mice in which the Erk2 gene was con-
ditionally deleted at two different stages in thymic de-
velopment. The analyses of these mice reveal that the
MAP kinase pathway differentially affects at least two
stages in thymic development.
Results
Mice with a Hemizygous Erk2 Deficiency Exhibit
Embryonic Lethality
Germline deletion of Erk2 was accomplished with a tar-
geting vector as depicted in Figure S1 in the Supple-
mental Data available with this article online. From 60
Erk2+/− × Erk2+/− offspring, no homozygous mice were
born. In addition, Erk2+/− mice were backcrossed to
C57BL/6 in two separate experiments, and the number
of heterozygous Erk2+/− progeny was tallied. As shown
in Figure S2, the number of progeny with a hemizygous
Erk2 deficiency decreased such that at generation four,
only one Erk2+/− mouse was recovered. When a genera-
tion-three mouse was crossed to strain SVJ/129, the
Erk2-deficient allele transmitted at a frequency of 50%.
There would seem to be a strict requirement for the full
level of Erk2 expression during development that can
be dominantly suppressed by one or more genes pre-
sent in the SVJ/129 strain. We did not determine the
stage at which development was aborted in the hemi-
zygous Erk2-deficient embryos, although we note that
three other Erk2 mutant strains exhibited homozygous
lethality at three different embryonic stages (Saba-El-
Leil et al., 2003; Yao et al., 2003; Hatano et al., 2003).
To avoid embryonic lethality, we modified the Erk2
locus by homologous recombination for conditional de-
letion (Figure 1A). Female mice containing the targeted
allele (Erk2fn) were bred with EIIa-cre transgenic mice,
and the progeny were screened for a recombination
event that retained exon 3 but deleted PGK-neo (Erk2f)
(Lakso et al., 1996; Holzenberger et al., 2000). Mouse
strains with either the Erk2f or Erk2fn alleles were used
to assess the requirement for Erk2 in T cell devel-
opment.
Deletion of Erk2 in DN3 Thymocytes
Decreases Thymic Cellularity
Germline transmission of each allele was tested by
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aSouthern blotting and PCR. Homozygous Erk2f/f andrk2fn/fn mice were found to express the same levels of
rk2 protein and have normal T cell development indi-
ating that the modification of the Erk2 locus with or
ithout PGK-neo did not disrupt gene regulation (Fig-
re 1B). Both alleles were crossed with pLck-cre trans-
enic mice in order to express the cre recombinase in
he T cell lineage prior to the β selection checkpoint
Lee et al., 2001; Wolfer et al., 2002). The two alleles
ere comparably expressed and deleted with no de-
ectable differences (Figure 1B). In order to determine
he stage of Erk2 deletion, we sorted DN3 and DN4
opulations and tested them for exon 3 deletion and
rk2-protein loss (Figure 1C). At the DN3 stage, exon
was still detectable by PCR amplification, and there
emained a substantial amount of protein. At the DN4
tage, we detected virtually no remaining Erk2 protein.
In mice deleted for Erk2, the numbers of total and
P thymocytes were reduced by about 30%, consistent
ith a partial block in the expansion associated with
he DN-to-DP transition or a reduction in cell survival
Figure 1D). In order to examine this directly, we ana-
yzed the DN subpopulations, as measured by the ex-
ression of CD25 and CD44, were analyzed (Figure 1E).
ndeed, there was a substantial increase in the number
f DN3 thymocytes, consistent with a partial block in
he DN3 to DN4 maturation step.
eletion of Both Erk1 and Erk2 Does Not Prevent
aturation to the DP Stage of Development
o determine the roles of Erk1/2 in the DN-to-DP transi-
ion, we crossed Erk2fn/fn;pLck-cre mice to mice with
germline deficiency in Erk1 (Pages et al., 1999). As
escribed above, thymocytes from Erk2f/f;pLck-cre
ice showed a partial block at the DN3 stage (Figures
E and 2A), although cells progressed to the DN4 stage
nd beyond. Densitometry of Erk2 protein (Figure 1C)
evealed that its expression was decreased approxi-
ately 3-fold at the DN3 stage and from 25–100-fold at
he DN4 stage. More importantly, in Erk1−/−;Erk2f/f;Lck-
re mice, the thymocytes progressed to the DN4 stage
nd, as we will show below, were competent to pro-
ress to the DP stage of development with no detecta-
le Erk1/2 protein remaining.
To investigate this partial block, we looked at two
ajor characteristics of DN-thymocyte development—
roliferation and TCR β chain expression. The rate of
hymocyte proliferation in vivo was assessed by in-
ecting bromodeoxyuridine (BrdU) and harvesting the
hymocytes 3 hr later. The result was that thymocytes
rom Erk2fn/fn;pLck-cre mice exhibited normal or even
lightly enhanced BrdU uptake in the DN4 population
Figure 2B). Surprisingly, this was true for thymocytes
rom Erk1−/−;Erk2fn/fn;pLck-cre mice as well. In addition,
e found a high degree of variability in the mice defi-
ient for both Erk isoforms. Whereas some mice had
ery small thymuses (13 × 106 cells) and few DN4 cells,
thers had larger thymuses (115 × 106 cells) with only
moderate block at the DN3 stage of development
Figure 2C). To determine the effectiveness of Erk2 de-
etion in the absence of Erk1, we isolated the DN3 and
N4 populations by cell sorting and analyzed them for
rk2 by western blotting. The results showed that, in the
bsence of Erk1, Erk2 protein was unchanged at the DN3stage and was reduced but still detectable at the DN4
T Cell Development in Erk-Deficient Mice
433Figure 1. Loss of Erk2 in Early Thymocyte
Development Causes a Decrease in Thymic
Cellularity
(A) A diagram representing the Erk2 locus
and targeting strategy used to generate two
targeted versions of the Erk2 allele.
(B) Western-blot analysis of Erk protein in to-
tal thymocyte lysates from mice with indi-
cated genotypes.
(C) Western-blot analysis and Erk2 exon 3
deletion in sorted DN3 (CD4−CD8−B220−
H-2Ab−γδ TCR−CD44−CD25+) and DN4 (CD4−
CD8−B220−H-2Ab−γδ TCR−CD44−CD25−) thy-
mocytes from Erk2f/f and Erk2f/f;pLck-cre
mice. Genomic Erk2 exon 3 deletion PCR
was carried out with primers p1, p2, and p3
as depicted in Figure 1A (see Experimental
Procedures for sequences).
(D) Graphical representation of total thymo-
cyte numbers and DP thymocyte numbers.
Data represent six Erk2fn/fn (wt) mice and
nine Erk2fn/fn;pLck-cre (Erk2−/−) mice.
(E) Graphical representation of DN subset
numbers. Subsets are classified as DN1
(CD44+CD25−), DN2 (CD44+CD25+), DN3
(CD44−CD25+), and DN4 (CD44−CD25−). Data
represent six Erk2fn/fn (wt) mice and nine
Erk2fn/fn;pLck-cre (Erk2−/−) mice.stage (Figure 2D). These data are consistent with the
selective survival of DN3 and DN4 cells that retain Erk2.
The decrease in cell number (Figure 2C) could also
be associated with increased cell death, although flow
cytometric analyses of directly explanted cells did not
reveal an excess of apoptotic cells either by staining
with annexin V or by forward and side light scatter (data
not shown). Because apoptotic cells are rapidly en-
gulfed, they may be detected only by an in situ analysis.
Nonetheless, all of the mice deficient for Erk1 and Erk2
possessed a substantial population of DP thymocytes
with no detectable protein expression remaining (see
below).
A second parameter we tested was the expression
of the TCR β chain. Erk-deficient DN3 cells expressed
normal levels of intracellular β chain, indicating that re-
arrangement and protein production were intact (Figure
2E). At the DN4 stage, there was an increased popula-
tion of cells from Erk2-deficient and Erk-deficient mice
that expressed no intracellular β chain. This result was
found consistently for Erk2-deficient DN4 thymocytes
defined as B220−MHCII−TCRγδ−CD4−8−25−44−90+ cells
(data not shown). These cells thus exhibit characteris-tics of DN4 cells without β chain expression. Although
γδ T cells were gated out in this analysis, we considered
the possibility that these cells could represent an in-
creased population of γδ T cells. Subsequent analyses
showed no significant change in the percentage of γδ T
cells within the DN subset (data not shown).
These experiments reveal that that Erk is required for
proliferation and differentiation associated with β selec-
tion, such that in the absence of Erk1, there is a selec-
tion for the retention of a small amount of Erk2. We infer
that under physiological conditions, Erk expression is
in excess over that which is required for continued pro-
liferation. As an aside, we note that the pLck-cre trans-
gene itself affects T cell development to an extent
(Mertsching et al., 2002), and it is thus essential in car-
rying out experiments of this type to compare cre trans-
genic mice with and without loxP-flanked alleles.
The Expression of Erk1/2 Is Essential
for Positive Selection
Thymocyte populations were measured by the expres-
sion of the CD4 and CD8 coreceptors, TCR β chain,
and CD69. As expected, the thymocyte subsets from
Immunity
434Figure 2. Erk2-Deficient Thymocytes Have a Partial DN3 Block
(A) DN thymocytes (CD4−CD8−B220−H-2Ab−γδTCR−) from the indicated mice were stained for CD44 and CD25. Population percentages are
indicated in the quadrants.
(B) DN3 and DN4 thymocytes from mice with indicated genotypes were injected and stained to indicate BrdU incorporation.
(C) Histogram of total numbers from nine Erk2fn/fn (wt) mice and nine Erk1−/−;Erk2f/f;pLck-cre (Erk−) mice; % = male andC = female.
(D) Western-blot analysis of Erk expression from sorted DN3 and DN4 thymocytes from Erk2fn/fn (wt) and Erk1−/−;Erk2fn/fn;Lck-cre (DKO) mice.
(E) DN3 and DN4 thymocytes from above mice were stained for intracellular β chain expression.Erk2f/f, Erk2fn/fn, and wild-type mice were not signifi-
cantly different (Figure 3A), although the introduction
of pLck-cre transgene appears to have caused a small
d
E
cecrease in mature thymocytes. The phenotype of
rk1+/+;Erk2f/+;pLck-cre mice was also similar to pLck-
re mice, and this is consistent with our analysis of thy-
T Cell Development in Erk-Deficient Mice
435Figure 3. Erk Activity Is Essential for Positive Selection
(A) CD4 and CD8 flow cytometric analyses of thymocyte populations were carried out from the indicated mice.
(B) Staining of total thymocytes from above mice with antibodies against CD69 and TCR.
(C) Mature (TCRhi) CD4 and CD8 thymocyte numbers from nine Erk2fn/fn (wt) mice and six Erk2fn/fn;plckcre (Erk2−/−) mice. CD4/CD8 ratio is a
calculation of the number of TCRhi CD4 divided by the number of TCRhi CD8.mocytes from Erk2+/− mice (Figure 3A and data not
shown). In this analysis, we also did not find a differ-
ence in the thymus subsets from mice that were defi-
cient only for Erk1. We surmise that the difference be-
tween this and the previous report may be ascribed to
genetic variations caused by backcrossing to C57BL/6
mice (Pages et al., 1999). In contrast, loss of both Erk
isoforms in Erk1−/−;Erk2fn/fn;pLck-cre mice was permis-
sive for the appearance of a substantial DP population,
but it was not permissive for the positive-selection-
associated appearance of mature CD4 or CD8 T cells.
Because the levels of TCR β chain and CD69 increase
with positive selection, we used a bivariant plot of
these two cell-surface molecules to reveal the percen-
tage of cells undergoing positive selection. As shown,
a small number of thymocytes undergo positive selec-
tion in the presence of Erk1, whereas virtually no
mature cells were detected in the absence of both iso-
forms (Figure 3B). These results show that the develop-
ment of a small number of single positive thymocytes
in Erk2f/f;pLck-cre mice was dependent on the activity
of Erk1, and this verifies previous results showing that
Erk1 plays a role in positive selection (Pages et al.,
1999). We can conclude that quantitatively, Erk2 is sub-stantially more important than Erk1, although we can-
not say whether this is due to abundance or activity.
Because Erk1 and Erk2 are both expressed in thymo-
cytes and appear to be at least partially redundant, a
deficiency in Erk2 alone constitutes the equivalent of a
hypomorphic mutation in this essential signaling path-
way. With this in mind, we plotted the number of CD4
and CD8 thymocytes found in Erk2-deficient mice and
their wild-type littermates. As depicted in Figure 3C, al-
though there is a decrease in both the CD4 and CD8
subsets, CD4 thymocytes are preferentially affected
such that the CD4:CD8 ratio goes from 3.2 in wild-type
mice to 2.2 in Erk2-deficient mice. An implication of this
result is, minimally, that CD4 T cell differentiation exhib-
its a greater dependence on Erk signaling compared
with CD8 differentiation.
Erk2fn/fn;Cd4-cre Mice Have Defects
in Positive Selection
Because Erk2f/f;pLck-cre mice demonstrated a partial
block in DN3 to DN4 progression, we were concerned
that this might carry over to later stages of develop-
ment. Therefore, to address the role of Erk2 in DP thy-
mocytes, we bred mice with the Erk2fn allele to coex-
Immunity
436press the later-deleting Cd4-cre transgene. Figure 4A
depicts the thymocyte subset analysis from a represen-
tative set of mice with different Erk genotypes. Once
again, mice with a hemizygous Erk2 deficiency were
within the range expected for wild-type mice, whereas
Erk2fn/fn;Cd4-cre mice exhibited a decrease in the num-
ber of CD4 and CD8 SPs. This phenotype was accen-
tuated by a deficiency in Erk1. Thymocytes that had
recently undergone positive selection were again enu-
merated by measuring the relative expression levels of
CD69 and the TCR β chain. By this measure, there was
a significant reduction in the percentage of positively
selected thymocytes in both Erk2fn/fn;Cd4-cre and
Erk1−/−;Erk2fn/fn;Cd4-cre mice. In comparison to dele-
tion with the pLck-cre transgene, overall thymic cellu-
larity was restored in Erk2fn/fn;Cd4-cre mice with an in-
crease in the proportion of DP thymocytes and a
compensatory decrease in single positive thymocytes
(Figure 4C). In contrast to Erk1/2-deficient mice gener-
ated with the pLck-cre transgene, Erk1−/−;Erk2fn/fn;Cd4-
cre mice retained significant populations of SP thymo-
cytes.
In order to determine the efficiency of deletion with
the Cd4-cre transgene, we sorted DP and CD4 thymo-
cytes and tested them for Erk2 protein and the Erk2
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(A) CD4 and CD8 flow cytometric analyses of thymocyte populations were carried out from the indicated mice. The top row depicts staining
with antibodies specific for CD4 and CD8, and the bottom row depicts staining with antibodies specific for CD69 and CD3.
(B) Western-blot analysis and Erk2 exon 3 deletion in sorted DP (CD4+CD8+) and SP (CD4 single positive) thymocytes. PCR was performed
as in Figure 1.
(C) Histogram representation of total and subpopulation thymocyte numbers and CD4/CD8 ratio. Data from nine mice Erk2fn/fn (wt) mice and
eight (Erk2−/−) Erk2fn/fn;Cd4-cre mice were graphed.xon 3 deletion. Although DP thymocytes had com-
letely deleted exon 3 of Erk2 as measured by PCR,
esidual Erk2 protein was easily detectable. The turn-
ver of Erk2 is such that it did not persist in CD4SP
hymocytes (Figure 4B). Again, a decrease in the
mount of Erk expressed was correlated with a de-
rease in the CD4-to-CD8 ratio of mature TCRhi thymo-
ytes (Figure 4C). We conclude that the few mature thy-
ocytes produced in Erk1−/−;Erk2fn/fn;Cd4-cre mice
ost likely achieved maturity as a result of enduring
rk2 protein in the DPs.
rk Deficiency Preferentially Affects
he CD4 Lineage
o further investigate the effects of decreased Erk2 activ-
ty on lineage commitment, we crossed the Erk2fn/fn;Cd4-
re or Erk2fn/fn;pLck-cre mice with TCR transgenic
ice: either an MHC-class-II-specific TCR (AND) (Kaye
t al., 1989) or an MHC-class-I-specific TCR (OT-I)
Hogquist et al., 1994). For comparison, we analyzed
CR transgenic mice with wild-type Erk1/2 loci or a
ermline Erk1 deletion.
The presence of an Erk1 deficiency did not result in
n alternation in the thymocyte subsets, and this is
onsistent with our analysis of T cell development in
T Cell Development in Erk-Deficient Mice
437Erk1-deficient mice without a TCR transgene. Although
there are apparent subtle differences in the examples
presented in Figure 5, these differences were within the
range of values characteristically found for AND mice
(Figure 5A and 5B). In contrast, AND;Erk2fn/fn;Cd4-cre
mice exhibited an altered proportion of DP and CD4
populations (Figure 5A). This was accompanied by a
reduction in the percentage of TCRhi, CD69hi, and
CD69lo thymocytes in AND;Erk2fn/fn;Cd4cre mice, sug-
gesting inefficient positive selection. Positive selection
was diminished further in AND;Erk1+/+;Erk2fn/fn;pLck-
cre mice and in AND;Erk1−/−;Erk2fn/fn;Cd4-cre mice, re-
flecting the reduced levels of total Erk molecules in
these two genotypes.
To reveal the percentage of cells that have completed
positive selection, we gated the CD69loVα11hi cells for
CD4 and CD8 (Figure 5C). This analysis revealed that
the number of CD4 cells diminished with levels of ex-
pressed Erk, and these cells were not replaced by ma-
ture CD8 thymocytes. As such, a simple decrease in Erk
activity is not sufficient to cause MHC-class-II-specific
thymocytes to differentiate into the CD8 lineage. We
did notice that the ratio of CD4 to CD8 T cells changedFigure 5. Erk2 May Not Determine Lineage
Commitment but Is Important for Progres-
sion of the CD4 Lineage
(A) Staining of total thymocytes from the in-
dicated strains with antibodies specific for
CD4 and CD8.
(B) Staining with antibodies specific for CD69
and Vα11.
(C) The CD69−Vα11+ (mature) cells were ana-
lyzed for the expression of CD4 and CD8.
The percentages of CD4+ and CD8+ cells
that fall within that gate are given. The boxed
numbers represent a ratio of percentage of
mature CD4 and CD8 T cells.
(D) Histogram of total thymocytes from the
indicated mice.dramatically. Whereas AND mice exhibited a CD4-to-
CD8 ratio of 257 in this example, AND;Erk2fn/fn;pLck-
cre mice exhibited a CD4-to-CD8 ratio of 20 (Figure 5C,
insert box). This was a consistent trend in dozens of
mice of different genotypes, and we interpret it to mean
that CD8 development has less of a requirement for
Erk-dependent signal transduction. Because the cells
were gated for a Vα11hi phenotype, we consider the
possibility that these cells express a second TCR α
chain to be unlikely. The total number of thymocytes
was also found to reflect the amount of Erk (Figure 5D),
even though the Cd4-cre transgene becomes tran-
scriptionally active subsequent to the expansion asso-
ciated with β selection. Because there is minimal prolif-
eration in the later stages of thymic development, this
decrease in cell number could reflect diminished cell
survival or accelerated migration into the peripheral
lymphoid organs.
A different result was obtained in the analysis of
OT-I mice. The development of CD8 thymocytes was
not as sensitive to the deletion of the Erk2 gene (Fig-
ures 6A–6C). Previous work has shown that at least a
subset of CD4+CD8lo thymocytes have received a posi-
Immunity
438Figure 6. Maturation of CD8 T Cells in OT-I Mice Is Insensitive to
Erk Expression
(A) Total thymocytes were stained with antibodies specific for CD4
and CD8.
(B) Thymocytes were stained with antibodies specific for CD24
(heat-stable antigen, HSA) and Vα2. Mature T cells were defined
as CD24loVα2hi.
(C) Mature T cells were analyzed for the expression of CD4 and CD8.
(D) The total numbers of thymocytes from the indicated strains
were plotted.
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mtive-selection signal and may or may not be committed
to one of the two T cell lineages (Lucas and Germain,
1996; Suzuki et al., 1997). Consistent with this idea, in
thymuses from OT-I mice decreases in Erk correlated
with decreases in the percentage of CD4+CD8lo thymo-
cytes, and this decrease was not entirely compensated
by the increase in thymocyte cell number (Figures 6A
and 6D). Yet, the maturation of CD8 OT-I thymocytes
was only minimally affected. This can be readily seen
by the ratio of CD4+CD8lo to CD4−CD8+ thymocytes
(Figure 6A).
h
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wIn the analysis of OT-I thymocytes, we found that a
ivariant plot of TCR (Vα2) versus CD69 did not yield
learly definable subsets, so we instead enumerated
he mature thymocytes on the basis of a Vα2hiHSAlo
henotype (Figure 6B). Again, we found that the ratio
f CD4 to CD8 mature thymocytes decreased with a
ecreased expression of Erk (Figure 6C, insert box)
ith one exception. In the Erk1/2-deficient mice, the
atio increased back to wild-type levels. We explain this
y noting that DPs in these mice have lower levels of
α2 and thus probably express endogenous TCR α
hains. We conclude that a partial loss of Erk2 in OT-I
ice had a marked effect on the efficiency of positive
election with less of an effect on the net steady-state
umber of mature CD8 thymocytes. We have no simple
xplanation for the reduced-Erk-associated increase in
otal thymocytes (Figure 6D), although perhaps Erk sig-
aling can play a role in cell death—either negative se-
ection caused by a superoptimal selection signal or
eath by neglect. Another possibility is that Erk does
ot mediate cell death, but with decreased Erk, fewer
hymocytes have been diverted into a nonproductive
D4 pathway.
rk1 and Erk2 Both Regulate Egr1 Expression
o investigate the contributions of Erk isoforms to the
egulation of downstream target genes, we examined
gr1 induction in DPs with or without the expression of
rk1/2. Egr1 is a zinc-finger transcription factor shown
o be important to thymocyte selection and is regulated
y the MAP kinase pathway (Bain et al., 2001; Bettini
t al., 2002). Thymocytes were analyzed for subsets
rom mice of varying genotypes and the DP thymocytes
solated by cell sorting (Figure 7A). The sorted DP thy-
ocytes were cultured for 45 min in the presence or
bsence of PMA, and a sample was used to detect the
mount of Erk1/2 expressed as a measure of the effi-
iency of recombination. As shown, the presence or ab-
ence of bands corresponding to Erk1 and Erk2 WT
atched the genotypes exactly (Figure 7B). As alluded
o above, this shows that the cells that complete matu-
ation to the double-positive stage of development are
ot those that managed to avoid Erk2 deletion.
Western blotting with anti-Egr-1 revealed a strong in-
uction by PMA after 45 min, and this induction was
irectly proportional to the amount of expressed Erk
Figure 7B). Erk1−/− mice generated approximately the
ame levels of Egr1 as wild-type, and DP thymocytes
rom Erk2fn/fn;pLck-cre mice induced substantially less
gr1 protein. Furthermore, Egr1 induction was com-
letely absent in cells from Erk1−/−;Erk2fn/fn;pLck-cre
ice. These results suggest that both Erk isoforms
ave the ability to regulate Egr1, but under the condi-
ions tested, Erk2 alone provides sufficient signaling to
aximally upregulate Egr1.
iscussion
n this report, we describe a newly derived strain of
ice in which the Erk2 gene can be inactivated by the
issue-specific expression of the cre recombinase. In
onjunction with a germline mutant allele of Erk1, we
ere able to dissect the role of these two canonical
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439Figure 7. Egr1 Induction in Erk Mutant Mice
CD3− DP thymocytes were cultured for 45 min with or without 10
ng/ml of PMA for 45 min. Lysates of stimulated and unstimulated
cells from the indicated mice were analyzed by western blotting for
Egr1 expression. ZAP-70 expression is shown as a loading control,
and Erk1/2 expression is shown to reveal the levels of Erk protein
present in the assayed population. Results are a representation of
three independent experiments.MAP kinases in several aspects of thymic develop-
ment.
In response to a wide variety of extracellular media-
tors, Erk is transiently activated, and in many cell types
it participates in differentiation, cell-cycle progression,
and survival (Pages et al., 1993; Xia et al., 1995; Gard-
ner and Johnson, 1996; Brunet et al., 1999; Walter et
al., 2000; Stemmann et al., 2001; Vaudry et al., 2002). In
addition, Erk is thought to be essential for the onco-
genic activity of Ras and Raf (Wan et al., 2004) and,
as such, an important mediator of cell-cycle regulation.
Most experiments carried out to characterize the role
of Ras-Erk signaling in mammalian cells have relied
upon the overexpression of gain-of-function mutants;
dominant-interfering forms of Ras, Raf, or Mek; or phar-
macological inhibitors of Mek. These experiments have
consistently shown that the Ras-Raf-Mek-Erk cascade
is important for growth-factor-receptor-mediated mito-genic activity, although individually, each approach has
limitations.
In keeping with these results, previous experiments,
including our own, showed that proliferation and differ-
entiation associated with the β selection checkpoint are
highly dependent on Mek (Crompton et al., 1996; Sharp
et al., 1997). To address this issue more conclusively,
we analyzed early thymic development in mice defi-
cient for Erk1/2; however, because Erk2 was condition-
ally deleted, there exists the potential for retention of
Erk2 protein during differentiation. By comparing the
signal in the DN4 subset from Erk1/2 knockout mice
with a titration of cell equivalents from wild-type mice,
we found that the decrease in Erk2 is less than 2-fold.
Presumably, only those DN4 cells with Erk2 continue to
divide, although the same is not true for the DP popula-
tion. The abundance of DPs allowed us to analyze ten
times as many cells, and yet we found no detectable
Erk-protein expression (Figure 7). We interpret these
data to show that Erk is necessary for proliferation as-
sociated with β selection, but not to complete the DN4
to DP differentiation step.
To account for the variability in the expansion of DN3
thymocytes and the retention of Erk2 protein at the DN4
stage, we propose that continued Erk signaling is re-
quired through at least the DN4 stage of development.
We speculate that the variability reflects the timing of
Erk2 deletion with respect to a productive TCR β chain
rearrangement. Those cells that complete a productive
rearrangement while retaining a sufficient level of Erk2
are able to sustain proliferation. Such a geometric ex-
pansion, sensitive to initial conditions, is likely to ex-
hibit a variable outcome.
The second checkpoint in thymocyte development is
positive selection and the associated fate specification
resulting in regulated differentiation of CD4 and CD8
T cells. In many unbiased genetic screens for genes
involved in fate specification associated with organo-
genesis, the MAP kinase pathway has been shown to
play an essential role. Cells receiving a strong signal
originating from a receptor tyrosine kinase adopt a pri-
mary cell fate, whereas cells receiving a weaker signal
can adopt a secondary fate depending on other signals
received (Wassarman et al., 1995; Kayne and Stern-
berg, 1995).
With these studies as a background, experiments
were carried out to characterize the role of Erk signal-
ing in T cell differentiation and lineage commitment.
Some studies relied upon the expression of dominant-
interfering forms of Ras, Raf and Mek; a hypersensitive
Erk mutant; or pharmacological inhibitors of Mek1/2
(Crompton et al., 1996; O’Shea et al., 1996; Swan et
al., 1995; Alberola-Ila et al., 1995; Sharp et al., 1997;
Bommhardt et al., 1999). Others inhibited signaling with
alternations in the TCR (Werlen et al., 2000; Delgado et
al., 2000). The results consistently showed a role for the
Erk pathway in proliferation and differentiation, yet they
were at odds on the issue of lineage commitment. The
thymocyte-specific expression of a hypersensitive Erk2
transgene favored CD4 development, and likewise Mek
inhibitors favored CD8 development. If CD4 and CD8
expression represent primary and secondary cell fates,
respectively, then this would be congruent with the
logic of fate specification established for organogene-
Immunity
440sis in simple metazoans. It is also consistent with a
model of thymocyte lineage commitment in which the
strength of signal through the TCR complex is deter-
ministic (Robey and Fowlkes, 1994; Zamoyska and Lo-
vatt, 2004; Taniuchi et al., 2004; Laky and Fowlkes, 2005).
Other results were not consistent with this role for Erk
signaling in T cell differentiation. The expression of
dominant-interfering forms of Ras and Mek potently in-
hibited positive selection, and yet there was no appar-
ent imbalance in CD4 and CD8 differentiation.
An analysis of the thymocytes deleted for Erk1, Erk2,
or both further demonstrate that Erk is not merely im-
portant, but is essential for positive selection and the
differentiation of DP thymocytes to either CD4 or CD8
T cells. Furthermore, none of the more distantly related
Erk family members substitute for Erk1 and Erk2. In ad-
dition, these results may be revealing with respect to
the process of lineage commitment. We observed that
the extent of positive selection was proportional to the
total amount of Erk present in DPs to the point where
there were virtually no CD4 or CD8 SP thymocytes in
the absence of both Erk1 and Erk2. We conclude that
the level of Erk signaling regulates the number of cells
that successfully pass the checkpoint of positive selec-
tion. Earlier experiments led to the same conclusion al-
though a similar level of inhibition was achieved by
transgenesis, resulting in a 30-fold overexpression of
catalytically inactive Mek (Alberola-Ila et al., 1995).
Other aspects of these transgenic mice were more diffi-
cult to understand because experiments analyzing early
thymocyte proliferation or T cell mitogenic responses
revealed no effects, whereas preliminary experiments
show that genetic ablation of Erk2 profoundly affects
the survival of activated T cells (W. D’Souza, A.M.F., and
S.M.H., unpublished observation). We emphasize that
all genetic or pharmacological manipulations result in
pleiotropic effects, and so understanding comes from
multiple independent approaches to a problem.
Consistent with a role for Erk beyond positive selec-
tion, we found that CD4 and CD8 thymocyte differentia-
tion exhibited a differential requirement for Erk. The ra-
tio of CD4 to CD8 SP thymocytes decreased with
decreasing amounts of Erk whether Erk2 was deleted
early with Lck-cre or later with Cd4-cre. These results
were reinforced by experiments with TCR transgenic
mice. Decreasing amounts of Erk had a proportionate
effect on the number of CD4 SP thymocytes in AND
mice, whereas equivalent losses of Erk had little affect
on the number of CD8 SPs in OT-I mice. Whether or not
the analyses were carried out with TCR transgenic
mice, the ratio of CD4 to CD8 SP thymocytes was de-
creased in proportion to the level of Erk expression.
The major question is whether the level of Erk (and
presumably Erk activity) is deterministic for CD4 and
CD8 lineage commitment analogous to its role in the
models cited above. In the present analysis, we found
that a progressive loss of signaling through the MAP
kinase pathway was not sufficient, in itself, to cause
MHC-class-II-specific thymocytes to assume a CD8
phenotype. This is in contradistinction to studies also
using AND TCR transgenic mice in which CD4 was
deleted (Matechak et al., 1996), ZAP70 activity was
temporally attenuated (Liu and Bosselut, 2004), or Lck
activity was diminished with a distal Lck-driven kinase-
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pead form of Lck (Hernandez-Hoyos et al., 2000). The
atter study is most analogous to the work presented
ere, and yet we note that an earlier analysis with the
ame dominant-negative Lck transgene did not observe
change in lineage commitment (Hashimoto et al., 1996).
n addition, diminished TCR signaling achieved via mu-
ations in the TCR zeta chain also did not cause a shift
o the CD8 lineage in AND mice (Shores et al., 1997).
One possibility is that the strength of signal affects
he probability that DPs will undergo positive selection
ith a bias, reinforced by selection, toward a given fate
Sharp and Hedrick, 1999; Davis et al., 1993; Leung et
l., 2001). Perhaps the present experiments did not de-
ect a lineage reversal because cells that made the de-
ision to become CD8SPs died as a consequence of
he associated loss of signaling through CD4. However,
his explanation is unsatisfactory because the same ca-
eat should apply to the studies cited above. A second
ossibility is that the strength of signal is deterministic
or fate specification, but it is not restricted to Erk acti-
ation. It includes other signaling networks such as the
elease of free calcium and the resulting activation of
alcineurin (Neilson et al., 2004). A third possibility is
hat the strength of signal only determines the prob-
bility of positive selection, and lineage commitment is
etermined by a combination of signal duration (Shao
t al., 1999; Wilkinson and Kaye, 2001; Adachi and
wata, 2002), selection (Leung et al., 2001), or both.
Several lines of experimentation demonstrate the
xistence of a selection process that could provide a
orm of proofreading to multiply the accuracy of lineage
ommitment. This is one interpretation of experiments
n which ectopically expressed coreceptors allow for a
mall population of misdirected T cells (Robey et al.,
994; Davis et al., 1993; Leung et al., 2001). Although
instruction” followed by “selection” would be an
ttractive model for accurate lineage commitment,
inger and his colleagues explain the available data in
he context of a coreceptor reversal model (Singer,
002). They propose that DP thymocytes receive a pos-
tive-selection signal that causes them to exhibit a
D4+CD8lo phenotype, and lineage commitment is sec-
ndarily determined by the presence or absence of
ontinued coreceptor signaling. Those cells that re-
eive sustained signals differentiate into CD4s and
hose for which signaling is attenuated become CD8s.
ost convincingly, Sarafova et al. have now shown that
he expression of CD4 under control of a CD8 enhancer
esults in the loss of CD4 expression upon positive se-
ection. In these mice, MHC-class-II-specific thymo-
ytes almost uniformly assume a CD8 cytotoxic pheno-
ype (Sarafova et al., 2005).
We favor a scheme in which the MAP kinase path-
ay, leading to the expression of Sap-1 (Costello et al.,
004), Egr1 (Bettini et al., 2002) and Id3 (Rivera et al.,
000), promotes positive selection and biases the dif-
erentiation toward either CD4 or CD8 depending on
he strength of activation. The loss of Erk preferentially
iminishes the propensity of progenitors to assume a
D4 phenotype, but this is not sufficient to produce a
hift to CD8 T cells. Presently, we cannot say whether
he critical step in lineage commitment comes from
ther signaling pathways or more simply reflects the
ersistence of signals through the CD4 coreceptor. The
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441interesting issue will be to determine how signaling and
selection combine to affect the expression of transcrip-
tion factors that appear to program lineage commit-
ment. One such factor is TOX, an HMG-box transcrip-
tion factor that appears to be conditionally sufficient for
CD8 differentiation (Aliahmad et al., 2004). Another is a
zinc-finger transcription factor previously known as
c-Krox (or Zfp-67), which has been found to determine
CD4 versus CD8 differentiation (Keefe et al., 1999; He
et al., 2005). It is newly designated as Th-POK, and in-
formation pertaining to its induction and the gene ex-
pression it elicits downstream may finally provide a mo-
lecular explanation for thymocyte lineage commitment.
Experimental Procedures
Mice
Mice harboring the erk2 exon 3 conditional allele were generated
by the UCSD Transgenic Mouse Core Facility as described in Sup-
plemental Experimental Procedures. The Erk2fn allele was typed
with the primers, 5#-GAACTTACTATGCACATCAGG-3# (p2 in Figure
1) and 5#-ACACAGTATGAGTCTCATTCC-3# (p3 in Figure 1). The
Erk2f allele was typed with the primers, 5#-TAGCAG GTGGATATC
TAAGC-3# (p1 in Figure 1) and 5#-GGTAACAAGAGCAACACGTGC-3#
(p4-Figure 1). Cd4-cre and Lck-cre mice were obtained from Ta-
conic Labs. OT-I mice were a gift from Kristen Hogquist. AND mice
were bred in our facility and backcrossed to C57BL/6 for nine gen-
erations. All mice were housed at UCSD under institutional guide-
lines.
FACS Analysis
For total thymocyte analysis, cells were stained with anti-
CD69FITC, anti-TCRβPE (H57), anti-CD8PerCP and anti-CD4APC.
For analysis of DN-thymocyte populations, cells were stained with
a biotin cocktail containing antibodies against CD4, CD8, γδTCR,
B220, and MHC class II and then stained with strepavidinPerCP,
CD25FITC, and CD44APC. For intracellular β chain staining via
H57PE, cells were fixed with Cytofix and permeablized by Cyto-
perm (BD Pharmingen) as per instructions by the manufacturer. All
fluorescent antibodies used in this study were purchased from
eBioscience except for PerCP antibodies that were purchased from
BD Pharmingen.
BrdU Analysis
Mice were innoculated with 100 l of a 10 mg/ml BrdU stock intra-
peritoneally 3 hr before the thymus was harvested. Thymocytes
were stained with the same biotin antibody cocktail as stated
above and then stained with strepavidin-PerCP, CD25PE, and
CD44APC. Cells were placed in BrdU buffer overnight (PBS, 0.01%
tween20, 1% paraformaldehyde). One milliliter of fresh 0.1 mg/ml
DNase was added and then incubated for 1 hr at 37°C. Cells were
stained with 10 l/106 cells of anti-BrdU FITC (BD Pharmingen) for
30 min at room temperature.
Western Analysis
5 × 106 thymocytes were lysed with high-salt lysis buffer (20 mM
Hepes [pH 7.9], 420 mM NaCl, 0.1 mM EDTA, 1.5 mM MgCl2, 25%
glycerol) with protease and phosphatase inhibitors (Cell Signaling).
Supernatants were separated by 10% polyacrylamide SDS gel
electrophoresis (BioRad) and transferred to a PVDF membrane
(Millipore). Blots were incubated with primary antibody at 4°C over-
night and secondary HRP antibody (Vector Labs) for 2 hr. ECL (Am-
ersham) chemistry was used to visualize protein products. Anti-Erk
antibodies were from Santa Cruz Biotech (C-14) and Zymed. The
anti-Egr1 antibody was obtained from Active Motif, and the ZAP-
70 mouse monoclonal antibody was obtained from Transduction
Laboratories.
Isolation of Thymocyte Subsets
DN3, DN4, DP, and CD4 thymocytes were sorted by The Scripps
Research Institute cell-sorting facility. Western blots were per-formed with extracts from 105 thymocytes, and PCR was per-
formed with 104 cells. Deletion of Erk2 exon 3 was analyzed with
p2 and p3 to detect loxP sequence and with p1 and p3 to detect
to loss of exon 3 (above).
Thymocyte Stimulations
Purification of preselecting DP thymocytes were done by first col-
lecting the CD3− fraction off of a MACS column (Miltenyi Biotech)
and then by collecting the CD8+ fraction. Two milliliters of 2.5 × 106
cells/ml of purified preselecting DP thymocytes were plated into a
35 mm dish. Samples were stimulated with 5 l of a 4 g/ml PMA
stock (CalBiochem) for 45 min. Stimulated and unstimulated sam-
ples were washed with 13 ml cold PBS and lysed as described
above.
Supplemental Data
Supp data include two Supplemental Figures and Supplemental
Experimental Procedures and are available at http://www.immunity.
com/cgi/content/full/23/4/431/DC1/.
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